Senores Pharmaceuticals shareholders and shareholding pattern
NSE: SENORESBSE: 544319Pharmaceuticals & BiotechnologySmall Cap
Last close ₹1,215.30up ₹12.70 (1.06%)BSE ₹1,213.90
Share price at the NSE close on 23 Oct 2026. Previous close ₹1,202.60.
52-week range of traded prices to 23 Oct 2026
₹706.00Low, 23 Mar 2026₹1,599.00High, 24 Aug 2026
- Next results date: the board meets on 29 Oct 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹5,597 Cr841st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 27 Jul 2026
- 42.6
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 27 May 2026
- 6.0
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 27 Jul 2026
- 15.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 27 Jul 2026
- 13.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 27 May 2026
- 0.34
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 1,65,74443.3% delivered
Who owns Senores Pharmaceuticals, filing by filing
Per cent of the company's shares. Every filing on record, from Dec 2024; the latest is the filing for Sep 2026.
Sep 2026 filing
- Promoters45.82%
- Foreign institutions6.01%
- Indian institutions10.84%
- Individuals and others37.33%
Shareholding pattern, per cent
- Promoters
- Foreign institutions
- Indian institutions
- Individuals and others
| Per cent | Dec 2024Filed 13 Jan | Mar 2025Filed 8 Apr | Jun 2025Filed 14 Jul | Sep 2025Filed 10 Oct | Dec 2025Filed 12 Jan | Mar 2026Filed 7 Apr | Jun 2026Filed 20 Jul | Sep 2026Filed 16 Oct |
|---|---|---|---|---|---|---|---|---|
| 45.76% | 45.77% | 45.78% | 45.80% | 45.80% | 45.82% | 45.82% | 45.82% | |
| Indian promoters | 39.45% | 39.45% | 39.46% | 39.51% | 39.52% | 39.54% | 39.54% | 39.60% |
| Foreign promoters | 6.32% | 6.32% | 6.32% | 6.28% | 6.28% | 6.28% | 6.28% | 6.22% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. | 54.24% | 54.23% | 54.22% | 54.20% | 54.20% | 54.18% | 54.18% | 54.18% |
| Promoter shares pledgedShare of the promoters' own shares | 0.00% | 0.00% | 0.00% | 0.00% | 1.90% | 1.90% | 2.81% | 2.81% |
| Shares in issue | 4,60,53,588 | 4,60,53,588 | 4,60,53,588 | 4,60,53,588 | 4,60,53,588 | 4,60,53,588 | 4,60,53,588 | 4,60,53,588 |
| Shares locked inShares locked in. Shares the filing reports as barred from sale until a set day, such as promoters' shares after a public issue or shares allotted to an investor directly. | 3,78,31,590 | 3,11,65,865 | 92,33,746 | 92,33,746 | 92,33,746 | 1,22,22,094 | 1,07,60,074 | – |
| Promoters' shares locked in | 2,10,76,079 | 2,10,76,079 | 92,33,746 | 92,33,746 | 92,33,746 | 1,22,22,094 | 1,07,60,074 | – |
Pledged is the share of the promoters' own shares given to lenders as security. A dash is a line the filing did not state. “Under 0.01%” is a holding of shares too small to show at two decimals.
Senores Pharmaceuticals promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is Swapnil Jatin Shah, 7.72%. The filing names 47 more members with no shares.Promoter buying and selling
| Holder | |||
|---|---|---|---|
| Swapnil Jatin ShahIndividuals and Hindu undivided families | 7.72% | 35,53,531 | 0.00% |
| Ashokbhai Vijaysinh BarotIndividuals and Hindu undivided families | 7.55% | 34,74,869 | 0.00% |
| Remus Pharmaceuticals LimitedIndian companies, trusts and others | 7.08% | 32,61,744 | 0.00% |
| Renosen Pharmaceuticals Private LimitedIndian companies, trusts and others | 5.90% | 27,18,719 | 0.00% |
| Anar Swapnil ShahIndividuals and Hindu undivided families | 4.98% | 22,94,500 | 0.00% |
| Aviraj Overseas LLCForeign companies and others | 4.12% | 18,95,190 | 0.00% |
| Sangeeta Mukur BarotIndividuals and Hindu undivided families | 2.26% | 10,42,955 | 0.00% |
| Aviraj Group LLCForeign companies and others | 1.49% | 6,84,750 | 0.00% |
| Espee Therapeutics LLPIndian companies, trusts and others | 1.07% | 4,95,000 | 80.81% |
| Jitendra Babulal SanghviIndividuals and Hindu undivided families | 1.06% | 4,88,516 | 0.00% |
| Mukur Yogeshkumar BarotIndividuals and Hindu undivided families | 0.99% | 4,56,825 | 42.25% |
| Shantaben Babulal SanghviIndividuals and Hindu undivided families | 0.71% | 3,28,569 | 0.00% |
Pledged is the share of the holder's own shares pledged to a lender.
Largest public holders of Senores Pharmaceuticals, filing by filing
Per cent, on the same shares as the split above.Mutual funds holding Senores Pharmaceuticals
| Holder | Dec 2024Filed 13 Jan | Mar 2025Filed 8 Apr | Jun 2025Filed 14 Jul | Sep 2025Filed 10 Oct | Dec 2025Filed 12 Jan | Mar 2026Filed 7 Apr | Jun 2026Filed 20 Jul | Sep 2026Filed 16 Oct |
|---|---|---|---|---|---|---|---|---|
| MANOJ PRAKASH SANGHVIResident individuals, over ₹2 lakh at face value | 1.88% | 1.88% | 1.88% | 1.86% | 1.86% | 1.86% | 1.86% | 1.86% |
| RATNAMANI MARKETING PRIVATE LIMITEDCompanies | 1.82% | 1.82% | 1.82% | 1.82% | 1.82% | 1.82% | 1.82% | 1.82% |
| ASTORNE CAPITAL VCC - ARVENForeign portfolio investors, category I | – | 1.83% | 2.16% | 2.14% | 1.36% | 1.53% | 1.95% | 1.36% |
| ADITYA BIRLA SUN LIFE INSURANCE COMPANY LIMITEDInsurance companies | 2.81% | 3.71% | 4.05% | 2.94% | 2.66% | 2.96% | 1.62% | 1.28% |
| JAYANTI MISHRIMAL SANGHVI .Resident individuals, over ₹2 lakh at face value | 1.45% | 1.45% | 1.45% | 1.23% | 1.23% | 1.23% | 1.23% | 1.23% |
| JIGAR PRAKASH SANGHVIResident individuals, over ₹2 lakh at face value | 1.19% | 1.19% | 1.19% | 1.19% | 1.19% | 1.19% | 1.19% | 1.19% |
| PRAKASH MISHRIMAL SANGHVIResident individuals, over ₹2 lakh at face value | 1.03% | 1.03% | 1.03% | 1.03% | 1.03% | 1.03% | 1.03% | 1.03% |
| Bishwanath Prasad AgrawalResident individuals, over ₹2 lakh at face value | – | – | – | – | 1.22% | – | – | – |
| Sanghavi Pavankumar Mishrimalji HufOther non-institutions | 1.10% | 1.10% | 1.10% | 1.10% | – | – | – | – |
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. Mutual funds are left out here: each fund's holding is on the Mutual funds tab, from its own portfolio. A dash is a filing that did not name the holder, which includes holding under one per cent.